Upper Respiratory Infections Clinical Trial
Official title:
An Open Label, In-use Study to Assess the Warming Sensation, Acceptability and Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup Given as a 30 ml Single Dose in Subjects Suffering From Symptoms of an Upper Respiratory Tract Infection
This is an open label, in-use study to assess the warming sensation, acceptability and local
tolerability of paracetamol 500 mg + pseudoephedrine 30 mg syrup, given as a single dose in
subjects suffering from symptoms of an upper respiratory tract infection. The purpose is to
evaluate the acceptability concerning a warming sensation effect and its potential benefit
in the target population.
The primary objective is to assess the warming sensation caused by the excipient IFF flavor
316 282, in a syrup containing paracetamol 500 mg + pseudoephedrine 30 mg per 30 ml syrup.
The syrup contains (0.15% w/v) warming flavor.
The Secondary Objectives are to assess subject acceptability of the syrup and the safety and
tolerability of the syrup. The study will be run in fifty-six (56) subjects suffering from
symptoms of an upper respiratory tract infection (URTI) for 7 days or less, e.g. nasal
congestion associated with colds and flu symptoms such as pain, headache and/or fever.
Subjects must have one or more symptoms per category:
1. mild to moderate body pain, headache, fever or sore throat
2. nasal congestion (blocked nose) with or without rhinorrhea (runny nose) or sneezing
Adolescents will be included in the study population
n/a
Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02451163 -
DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly
|
Phase 2 | |
Recruiting |
NCT01971112 -
Nutritional Intervention and Respiratory Infections in Older Subjects
|
N/A | |
Completed |
NCT01717534 -
Children Immune Functions
|
N/A | |
Completed |
NCT01728090 -
Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections
|
Phase 4 | |
Completed |
NCT00235703 -
Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)
|
N/A | |
Completed |
NCT02232711 -
Evaluation of Accuracy and Ease of Use of the FilmArray™ Respiratory Panel (RP EZ) in a CLIA-Waived Clinical Setting
|
N/A | |
Completed |
NCT01731392 -
Children Immune Functions(2)
|
N/A | |
Withdrawn |
NCT00773435 -
Effects of Echinacea in Children
|
N/A | |
Completed |
NCT03464279 -
Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections
|
N/A | |
Completed |
NCT01576809 -
Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)
|
Phase 3 | |
Completed |
NCT00611195 -
Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI
|
Phase 4 | |
Completed |
NCT02225912 -
A Study to Evaluate the Efficacy of the Nasal Antiseptic, PrevinC, When Administered for the RiskReduction of Rhinitis in Subjects Who Work for Child Day Care Centers
|
Phase 4 |